Certificate in Industry Essentials 5.0 — Clinical Research and Trials

Core topics

• Clinical Research and Trials Fundamentals and Terminology
• Planning and Demand Management in the Clinical Research and Trials Sector
• Sourcing, Supplier Selection and Contract Basics
• Supplier Performance, Risk and Continuity
• Cost, Value and Commercial Decision-Making
• Data, Digital Tools and Professional Judgment

1. 

   1.Before There Was Clinical Research

   • James Lind Aboard HMS Salisbury, 1747
   • The First Controlled Trial in Medicine
   • Two Centuries Before Controls Were Required
   • The Conditions That Had to Come First
   • The Problem the First Trials Were Built to Solve
   • The Supply Chain Hiding in the Scurvy Ward
2. 

   2.The People Who Built Clinical Research

   • Austin Bradford Hill Brings Statistics to Medicine
   • Randomization Enters the Clinic
   • Frances Kelsey Refuses to Sign
   • The Regulator Who Was Right
   • The Price Each of Them Paid
   • What the Pioneers Left for Procurement
3. 

   3.The Catastrophe That Wrote the Clinical Research Rulebook

   • Every Regulation Is a Scar
   • Thalidomide and the Children It Harmed
   • The Modern Drug Approval System Is Born
   • Tuskegee and the Consent That Was Never Sought
   • Informed Consent Written Into Law
   • Reading the Rulebook Backward
4. 

   4.What Clinical Research Got Spectacularly Right

   • The Achievement Worth Studying: The COVID 19 Trials
   • Tens of Thousands Enrolled in Months
   • Speed and Rigor Are Not Opposed
   • Why It Is Harder Than It Looks
   • What the Industry Can Do When It Decides To
   • The Supply and Logistics Behind the Readout
5. 

   5.Clinical Research: Booms, Busts and Absurdities

   • The Outsourcing Wave and the Birth of the CRO
   • Decentralized and Adaptive Designs Find Their Footing
   • The Placebo That Works When You Admit It
   • When Time Is the Most Expensive Line Item
   • Funny, Mostly; Instructive, Always
   • Every Fossil Was Once a Sourcing Decision
6. 

   6.Follow the Money in Clinical Research

   • What the Industry Actually Sells
   • Evidence the Regulator Will Accept
   • The Cost Base of a Typical Operator
   • Fixed Against Variable, Bought Against Built
   • Where the Margin Actually Sits
   • Who Captures Value and Who Handles Volume
7. 

   7.Clinical Research From One End to the Other

   • Protocol Design and the First Decisions
   • Site Selection and the Race to Activate
   • Investigational Product Reaches the Site
   • Recruitment, Data Capture and Monitoring
   • The Handoffs That Cause the Trouble
   • The Moving Line Between Make and Buy
8. 

   8.The Clinical Research Supply Base and Everyone in the Room

   • Everyone in the Room
   • Who Holds Power Over Whom
   • CROs, Central Labs and Site Services
   • Comparators, Cold Chain and the IRT System
   • Small Volume, High Value, Temperature Bound
   • Concentrated or Fragmented, and How Easily Replaced
9. 

   9.Commercial and Data Norms in Clinical Research

   • How Deals Are Actually Structured
   • Master Service Agreements and the Change Order
   • Site Payment Schedules and Comparator Supply
   • The Standards and Identifiers the Sector Runs On
   • When the Data Formats Do Not Agree
   • Cyber and Operational Technology as Supply Risk
10. 

    10.The Clinical Research Rulebook and Its Enforcers

    • ICH GCP and the Sponsor's Obligations
    • GMP for the Investigational Product
    • Ethics Committee Approval Before Anyone Enrolls
    • Trial Regulation, Region by Region
    • Who Inspects and Who Can Shut You Down
    • A Fine or a Criminal File
11. 

    11.The People Who Do the Work in Clinical Research

    • Who Works in the Sector
    • Career Paths and Professional Bodies
    • Qualifications That Carry Weight, and Those That Do Not
    • The Ethical Pressure Points
    • The Judgment That Stays Human
    • The Procurement Talent the Turn Demands
12. 

    12.What Is Industry 5.0, and What Does It Mean for Clinical Research?

    • What the European Commission Set Out
    • Human Centricity, Resilience and Sustainability
    • What Industry 4.0 Left Out
    • Where the Three Values Land Unevenly
    • The Value Clinical Research Was Trained to Neglect
    • Why the Chain Decides Which Value Wins
13. 

    13.Robots, Algorithms and People in Clinical Research

    • Together, Not in Succession
    • Where Machines Carry the Repetition
    • Where People Carry the Judgment
    • A Boundary Designed, Not Discovered
    • The Constraint Patient Safety Imposes
    • The Sourcing Decisions Machines Still Cannot Make
14. 

    14.What the Machines Are Actually Doing in Clinical Research

    • Recruitment and Site Selection Modeling
    • Protocol Feasibility Before the First Patient
    • Risk Based Monitoring in Practice
    • Safety Signal Detection at Scale
    • Deployed Capability Versus Vendor Projection
    • The Task an Agent Now Runs Alone
15. 

    15.The Bill Arrives: The Clinical Research Environmental Account

    • The Account Coming Due
    • Trial Travel and the Shipping Miles
    • Single Use Consumables and Their Cost
    • Decentralized Against Site Based Emissions
    • Regulated, Demanded, or Still Voluntary
    • How Fast the Voluntary Column Empties
16. 

    16.Built to Bend: Resilience in Clinical Research

    • A Trial That Cannot Afford to Pause
    • Continuity of Supply as Patient Safety
    • The Shock the System Did Not Plan For
    • Efficiency Against the Capacity to Absorb
    • Who Is Entitled to Make the Call
    • Resilience as a Procurement Decision
17. 

    17.Who Actually Decides in Clinical Research?

    • The Two Decisions That Set the Timeline
    • Comparator Sourcing and CRO Contracting
    • One Sourcing Decision, Followed All the Way
    • Its Effect on Cost, Risk and Compliance
    • How Few People Were in the Room
    • Why Procurement Owns the Trial's Fate
18. 

    18.In Clinical Research, the Chain Is the Business

    • Drug Accountability From Dispense to Return
    • Randomization Drives the Supply
    • Temperature Integrity and the Cold Chain
    • One Flow Decision, Followed Through
    • Service, Working Capital and Continuity
    • Why the Chain, Not the Molecule, Is the Business
19. 

    19.What Clinical Research Now Requires, and Why Depth Wins

    • Reading GCP, Liability and Logistics Together
    • What the Job Now Demands
    • The Distance Between Then and Now
    • Why Sector Depth Beats General Competence
    • The Judgment a Business Will Trust
    • The Knowledge That Walks Out the Door
20. 

    20.An Honest Look at Your Own Clinical Research Operation

    • A Self Assessment Against the Three Values
    • Comparator Availability and Single Source CRO Risk
    • Site Activation Delay and the Cost of a Late Day
    • Cold Chain Excursion and What It Voids
    • Where Your Automation Boundary Sits
    • The Readiness View You Take Back
21. 

    20 modules, 60 guided hours, 97 case studies, mastering the journey from protocol to patient through supply chain, sourcing, and procurement.